UNRESOLVED ISSUES. “While it is rare that cataloguing mutations in cancer alone will reveal both mechanisms of disease progression and potential drugable targets, we are left with the greater challenge of understanding how some cancers can relapse after treatment.”
https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1
linkedin post 2022-06-29 05:12:48
Nigel Fleming
September 21, 2022